Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sequential vs Concurrent Chemoradiotherapy in NPC (SANDWICH)
NCT03366415Phase 3Unknown
- Start
- Jan 2018
- Primary completion
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of gemcitabine, cisplatin in nasopharyngeal carcinoma (NPC). Status: unknown.
02
Drugs
gemcitabinecisplatin
03
Conditions
nasopharyngeal carcinoma (NPC)
Beyond the preview
Go deeper on NCT03366415.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03366415.